Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

sector : Health technology    crawled date : 2021 - 11 - 15    save search

Inhibikase Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Period Activity
Published: 2021-11-15 (Crawled : 23:00) - prnewswire.com
IKT | News | $2.13 0.19% 28K twitter stocktwits trandingview |
Health Technology
| | O: -0.78% H: 0.29% C: -5.58%

financial results results
Ensysce Biosciences Reports Third Quarter 2021 Financial Results and Recent Corporate Updates
Published: 2021-11-15 (Crawled : 23:00) - globenewswire.com
ENSC | $0.5805 -7.83% -8.49% 90K twitter stocktwits trandingview |
Health Technology
| | O: -6.07% H: 1.62% C: -24.63%

financial results results bioscience
Déclarations de Transparence d’Actionnaires de MDxHealth
Published: 2021-11-15 (Crawled : 22:00) - mdxhealth.com
SYK | $327.45 -2.55% 0.0% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.04% H: 0.69% C: 0.12%
HOLX | $75.1 0.24% 0.24% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.34% H: 0.0% C: 0.0%
EXAS | $63.45 0.36% 0.36% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -2.12% H: 0.0% C: 0.0%


MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States
Published: 2021-11-15 (Crawled : 22:00) - mdxhealth.com
SYK | $327.45 -2.55% 0.0% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.04% H: 0.69% C: 0.12%
HOLX | $75.1 0.24% 0.24% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.34% H: 0.0% C: 0.0%
EXAS | $63.45 0.36% 0.36% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -2.12% H: 0.0% C: 0.0%

offering
INVO Bioscience Reports Third Quarter 2021 Financial and Operating Results and Provides Business Update
Published: 2021-11-15 (Crawled : 22:00) - invobioscience.com
INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.38% C: -1.82%

results bioscience
Arcadia Biosciences Announces Strong Third-Quarter Financial Results and Business Highlights
Published: 2021-11-15 (Crawled : 22:00) - arcadiabio.com
RKDA | $2.0 -1.47% -1.5% 17K twitter stocktwits trandingview |
Health Technology
| | O: -1.46% H: 0.0% C: -5.42%

financial results results bioscience
Evofem Biosciences Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-11-15 (Crawled : 21:00) - prnewswire.com
EVFM | $0.0136 -16.94% 600K twitter stocktwits trandingview |
Health Technology
| | O: -21.8% H: 12.5% C: 7.88%

financial results results bioscience
Cytokinetics to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
Published: 2021-11-15 (Crawled : 21:00) - globenewswire.com
CYTK | $67.0 -1.37% -1.39% 890K twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 2.9% C: -0.23%

conference
CoImmune, Inc. Appoints Ed Baracchini, PhD, Chairman of the Board of Directors
Published: 2021-11-15 (Crawled : 21:00) - biospace.com/
LBPS | $1.65 -0.61% twitter stocktwits trandingview |
Manufacturing
| | O: -1.57% H: 5.89% C: 5.89%
INMB | $8.79 4.27% 4.1% 98K twitter stocktwits trandingview |
Health Technology
| | O: -0.96% H: 3.48% C: 0.56%


Six-Year Natural History Comparison with Mirum’s LIVMARLI (maralixibat) Demonstrates Event-Free Survival and Transplant-Free Survival in Patients with Alagille Syndrome
Published: 2021-11-15 (Crawled : 20:00) - biospace.com/
MIRM | $23.6 -1.05% -1.06% 400K twitter stocktwits trandingview |
Health Technology
| | O: -0.31% H: 1.01% C: -2.15%

syndros
CymaBay Therapeutics Long-term Open Label Study Finds Treatment with Seladelpar for Two Years Improves Key Liver Biomarkers in Patients with PBC
Published: 2021-11-15 (Crawled : 20:00) - biospace.com/
CBAY | $32.48 0.03% 8.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 3.17% C: -2.72%

treatment liver biomarkers
Cocrystal Pharma Reports Third Quarter Financial Results and Provides an Update on Development Programs and Milestones
Published: 2021-11-15 (Crawled : 20:00) - biospace.com/
COCP | $1.43 -1.39% 5.1K twitter stocktwits trandingview |
Health Technology
| | O: -0.88% H: 3.32% C: 1.11%

financial results results milestone pharma
Su Young Kim, M.D., Ph.D.
Published: 2021-11-15 (Crawled : 20:00) - nurixtx.com
NRIX 2 d | $14.43 2.49% 2.43% 970K twitter stocktwits trandingview |
Health Technology
| | O: -1.34% H: 0.92% C: -1.51%


Michael Mischke-Reeds
Published: 2021-11-15 (Crawled : 20:00) - nurixtx.com
NRIX 2 d | $14.43 2.49% 2.43% 970K twitter stocktwits trandingview |
Health Technology
| | O: -1.34% H: 0.92% C: -1.51%


Seema P. Rogers, M.S.
Published: 2021-11-15 (Crawled : 20:00) - nurixtx.com
NRIX 2 d | $14.43 2.49% 2.43% 970K twitter stocktwits trandingview |
Health Technology
| | O: -1.34% H: 0.92% C: -1.51%

ema
Kim Trahan
Published: 2021-11-15 (Crawled : 20:00) - nurixtx.com
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.14% H: 0.0% C: 0.0%
NRIX 2 d | $14.43 2.49% 2.43% 970K twitter stocktwits trandingview |
Health Technology
| | O: -1.34% H: 0.92% C: -1.51%


Ena Wang, M.D., M.S.
Published: 2021-11-15 (Crawled : 20:00) - nurixtx.com
NRIX 2 d | $14.43 2.49% 2.43% 970K twitter stocktwits trandingview |
Health Technology
| | O: -1.34% H: 0.92% C: -1.51%


Arrowhead Collaborator Presents Phase 2b Clinical Data from REEF-1 Study in Patients with Chronic Hepatitis B Infection
Published: 2021-11-15 (Crawled : 19:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| | O: -1.36% H: 0.0% C: 0.0%
ARWR | $22.62 0.4% 0.4% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: -3.29% H: 0.86% C: -10.19%

phase 2 hepatitis phase 2b injection infections chronic hepatitis b
iBio Announces Collaboration with UT Southwestern to Investigate IBIO-100 in Solid Tumors
Published: 2021-11-15 (Crawled : 19:00) - globenewswire.com
IBIO | $1.77 -6.35% -0.57% 180K twitter stocktwits trandingview |
Health Technology
| | O: -6.01% H: 0.0% C: 0.0%

solid tumors collaboration announces collaboration
COVID-19 Vaccine Perspectives Survey Illustrates Importance of Physician-Patient Communication and Prioritization of Disability Community and their Caregivers in Public Health Campaigns
Published: 2021-11-15 (Crawled : 18:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| | O: -1.36% H: 0.0% C: 0.0%

covid communication vaccine
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.